Adaptive Biotechnologies Corp
NASDAQ:ADPT
EV/OCF
Enterprise Value to OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
Market Cap | EV/OCF | ||||
---|---|---|---|---|---|
US |
Adaptive Biotechnologies Corp
NASDAQ:ADPT
|
391.7m USD | -0.3 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.6B USD | 29.1 | ||
US |
Danaher Corp
NYSE:DHR
|
181.8B USD | 26.9 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
42.6B USD | 25.2 | ||
CH |
Lonza Group AG
SIX:LONN
|
37.9B CHF | 28 | ||
US |
Agilent Technologies Inc
NYSE:A
|
40.3B USD | 21 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
54.8T KRW | 32.4 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
26.8B USD | 29.7 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.8B USD | 33.5 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
25.4B USD | 24.7 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
18.9B EUR | 33.4 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.